The results showed that the FGF9 expression level was higher and more common in CAFs than that in tumor cells, which was present not only in primary tumors but also in lymph node metastatic sites, indicating that FGF9 was mainly secreted by CAFs rather than by cancer cells. This evidence concerns the gene FGF9 and cancer.